Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001214659-25-004902
Filing Date
2025-03-27
Accepted
2025-03-27 16:30:58
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 b325250s1a.htm S-1/A 245990
3 EXHIBIT 5.1 ex5_1.htm EX-5.1 12906
4 EXHIBIT 23.1 ex23_1.htm EX-23.1 3057
5 EXHIBIT 23.2 ex23_2.htm EX-23.2 3486
6 GRAPHIC olshanlogo_header.jpg GRAPHIC 7594
7 GRAPHIC olshanaddress_header.jpg GRAPHIC 10740
8 GRAPHIC olshan_footer.jpg GRAPHIC 5478
9 GRAPHIC olshanwebaddy_footer.jpg GRAPHIC 5890
10 GRAPHIC alzamendlogo_regmark.jpg GRAPHIC 17222
11 filename11.htm CORRESP 8716
  Complete submission text file 0001214659-25-004902.txt   340601
Mailing Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326
Business Address 3500 LENOX RD. NE SUITE 1500 ATLANTA GA 30326 844-722-6333
Alzamend Neuro, Inc. (Filer) CIK: 0001677077 (see all company filings)

EIN.: 811822909 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-1/A | Act: 33 | File No.: 333-285788 | Film No.: 25779908
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)